The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 5,801–5,900 of 31,469
Yamada, C., Kondo, M., Kishimoto, N., Shibata, T., Nagai, Y., Imanishi, T., Oroguchi, T., Ishii, N., & Nishizaki, Y. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12323 · Cited by 64
Blé‐Castillo, J. L., Aparicio-Trápala, M. A., Francisco-Luria, M. U., Córdova-Uscanga, R., Rodríguez-Hernández, A., Méndez, J. D., & Díaz-Zagoya, J. C. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7051953 · Cited by 65
Polycystic Ovary Syndrome: Early Detection in the Adolescent
Chang, R. J., & Coffler, M. S. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31802f50fc · Cited by 60
Gao, H., Hägg, S., Sjögren, P., Lambert, P. C., Ingelsson, E., & van Dam, R. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12429 · Cited by 62
Kramer, C. K., Choi, H., Zinman, B., & Retnakaran, R. R. (2014) · Diabetes Care · doi:10.2337/dc13-2591 · Cited by 61
Diagnostic criteria for sarcopenia relate differently to insulin resistance
Bijlsma, A. Y., Meskers, C. G. M., van Heemst, D., Westendorp, R. G. J., de Craen, A. J. M., & Maier, A. B. (2013) · AGE · doi:10.1007/s11357-013-9516-0 · Cited by 61
Liang, J., Fu, J., Jiang, Y., Dong, G., Wang, X., & Wu, W. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0456-y · Cited by 63
Kanaka‐Gantenbein, C., Margeli, A., Pervanidou, P., Sakka, S. D., Mastorakos, G. P., Chrousos, G. P., & Papassotiriou, I. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.099002 · Cited by 61
Guilder, G. P. V., Stauffer, B. L., Greiner, J. J., & DeSouza, C. A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01281.2007 · Cited by 61
Stenholm, S., Koster, A., Alley, D. E., Visser, M., Maggio, M. G., Harris, T. B., Egan, J. M., Bandinelli, S., Guralnik, J. M., & Ferrucci, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03742.x · Cited by 65
Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD Patients
Kobayashi, S., Oka, M., Maesato, K., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00010108 · Cited by 61
Liu, L., Zheng, T., Wang, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1258 · Cited by 61
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome
Brennan, K., Huang, A., & Azziz, R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.101 · Cited by 61
Ergin, T., Lembet, A., Duran, E. H., Kuşçu, E., Bağış, T., Saygili, E., & Batıoğlu, S. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119634 · Cited by 61
Nappo, A., Iacoviello, L., Fraterman, A., González‐Gil, E. M., Hadjigeorgiou, C., Mårild, S., Molnár, D., Moreno, L. A., Peplies, J., Sioen, I., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000101 · Cited by 69
Obstructive sleep apnoea and metabolic impairment in severe obesity
Gasa, M., Salord, N., Fortuna, A. M., Mayos, M., Vilarrasa, N., Dorca, J., Montserrat, J. M., Bonsignore, M. R., & Monasterio, C. (2011) · European Respiratory Journal · doi:10.1183/09031936.00198810 · Cited by 62
Linden, M. A., Pincu, Y., Martin, S. A., Woods, J. A., & Baynard, T. (2014) · Physiological Reports · doi:10.14814/phy2.12071 · Cited by 64
Sevastianova, K., Sutinen, J., Kannisto, K., Hamsten, A., Ristola, M. A., & Yki‐Järvinen, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90224.2008 · Cited by 61
Marini, M. A., Frontoni, S., Mineo, D., Bracaglia, D., Cardellini, M., de Nicolais, P., Baroni, A., D’Alfonso, R., Perna, M., Lauro, D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021716 · Cited by 60
Nallasamy, P., Viswanathan, P., & Anuradha, C. V. (2008) · Renal Failure · doi:10.1080/08860220802134532 · Cited by 61
Newcomer, J. W., Ratner, R. E., Eriksson, J. W., Emsley, R. A., Meulien, D., Miller, F., Leonova-Edlund, J., Leong, R. W., & Brecher, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04132 · Cited by 62
Alcohol consumption and diabetes risk in the Diabetes Prevention Program
Crandall, J. P., Polsky, S., Howard, A. A., Perreault, L., Bray, G. A., Barrett-Connor, E. L., Brown-Friday, J., Whittington, T., Foo, S. T., Ma, Y., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27382 · Cited by 60
Soresi, M., Noto, D., Cefalù, A., Martini, S., Vigna, G., Fonda, M., Manzato, E., Cattin, L., Fellin, R., Averna, M., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-012-0406-1 · Cited by 53
Pourhassan, M., Bosy‐Westphal, A., Schautz, B., Braun, W., Glüer, C., & Müller, M. J. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.071829 · Cited by 61
Fisac, C., Virgili, N. M., Ferrer, E., Barberà, M. J., Fumero, E., Vilarasau, C., & Podzamczer, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021830 · Cited by 61
High Prevalence of Subclinical Left Ventricular Dysfunction in Patients with Psoriatic Arthritis
Shang, Q., Tam, L., Yip, G. W., Sanderson, J. E., Zhang, Q., Li, E. K., & Yu, C. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.101136 · Cited by 61
Rana, S., Blowers, E. C., & Natarajan, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401994c · Cited by 63
Changes of insulin sensitivity and secretion after bariatric/metabolic surgery
Mingrone, G., & Cummings, D. E. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.05.013 · Cited by 64
Pοlyzos, S. A., Kountouras, J., Tsatsoulis, A. A., Zafeiriadou, E., Katsiki, E., Patsiaoura, K., Zavos, C., Anastasiadou, V., & Slavakis, A. (2013) · HORMONES · doi:10.1007/bf03401306 · Cited by 63
Soy Reduces Bone Turnover Markers in Women During Early Menopause: A Randomized Controlled Trial
Sathyapalan, T., Aye, M., Rigby, A. S., Fraser, W. D., Thatcher, N. J., Kilpatrick, E. S., & Atkin, S. L. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2927 · Cited by 61
Chondronikola, M., Harris, L.-A. L. S., & Klein, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12527 · Cited by 62
Physiologically assessed hot flashes and endothelial function among midlife women
Thurston, R. C., Chang, Y., Barinas‐Mitchell, E., Jennings, J. R., von Känel, R., Landsittel, D., & Matthews, K. A. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000857 · Cited by 61
Ullah, K., Rahman, T. U., Wu, D., Lin, X.-H., Liu, Y., Guo, X., Leung, P. C. K., Zhang, R., Huang, H., & Sheng, J. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.013 · Cited by 61
Perfluoroalkyl substances and glycemic status in pregnant Danish women: The Odense Child Cohort
Jensen, R. C., Glintborg, D., Timmermann, C. A. G., Nielsen, F., Kyhl, H. B., Andersen, H. R., Grandjean, P., Jensen, T. K., & Andersen, M. (2018) · Environment International · doi:10.1016/j.envint.2018.04.010 · Cited by 61
Epigenome-wide association study of adiposity and future risk of obesity-related diseases
Campanella, G., Gunter, M. J., Polidoro, S., Krogh, V., Palli, D., Panico, S., Sacerdote, C., Tumino, R., Fiorito, G., Guarrera, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0064-7 · Cited by 63
Li, G., Esangbedo, I. C., Xu, L., Fu, J., Li, L., Feng, D., Han, L., Xiao, X., Li, M., Mi, J., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0707-y · Cited by 63
Circulating extracellular vesicles are associated with lipid and insulin metabolism
Kobayashi, Y., Eguchi, A., Tempaku, M., Honda, T., Togashi, K., Iwasa, M., Hasegawa, H., Takei, Y., Sumida, Y., & Taguchi, O. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00160.2018 · Cited by 62
Papandreou, C., Bulló, M., Zheng, Y., Ruiz‐Canela, M., Yu, E., Guasch‐Ferré, M., Toledo, E., Clish, C. B., Corella, D., Estruch, R., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy058 · Cited by 65
Drabsch, T., Holzapfel, C., Stecher, L., Petzold, J., Skurk, T., & Hauner, H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00556 · Cited by 61
Kim, B., Choi, H. Y., Kim, W., Ahn, C., Lee, J., Kim, J. G., Kim, J., Shin, H., Yu, J. M., & Moon, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206994 · Cited by 60
Castellino, G., Nikolić, D., Magán‐Fernández, A., Malfa, G. A., Chianetta, R., Patti, A. M., Amato, A., Montalto, G., Toth, P. P., Banach, M., et al. (2019) · Nutrients · doi:10.3390/nu11112580 · Cited by 63
Soleimani, D., Rezaie, M., Rajabzadeh, F., Navashenaq, J. G., Abbaspour, M., Miryan, M., Razmpour, F., Ranjbar, G., Rezvani, R., Jarahi, L., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6937 · Cited by 64
Peris‐Sampedro, F., Cabré, M., Basaure, P., Reverte, I., Domingo, J. L., & Colomina, M. T. (2015) · Environmental Research · doi:10.1016/j.envres.2015.06.036 · Cited by 61
Μacut, D., Panidis, D., Glišić, B., Spanos, N., Petakov, M. S., Bjekić, J., Stanojlović, O. P., Rousso, D., Kourtis, A., Antić, I. B., et al. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-014 · Cited by 61
Glycaemic instability is an underestimated problem in Type II diabetes
Praet, S., MANDERS, R. J. F., Meex, R. C. R., Lieverse, A. G., Stehouwer, C. D. A., Kuipers, H., KEIZER, H. A., & van Loon, L. J. C. (2006) · Clinical Science · doi:10.1042/cs20060041 · Cited by 61
de Carvalho, C. P., Marin, D. M., de Souza, A. L., Pareja, J. C., Chaim, É. A., de Barros-Mazon, S., da Silva, C. A., Geloneze, B., Muscelli, E., & Alegre, S. M. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9678-5 · Cited by 61
González‐Sánchez, J. L., Martínez-Larrad, M. T., Aben, K. K. H., Pérez‐Barba, M., & Serrano‐Ríos, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1129-2 · Cited by 60
Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus
Morris, B. W., Kouta, S., Robinson, R. T. C. E., MacNeil, S., & Heller, S. R. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00342.x · Cited by 61
Cheung, B. M. Y., Ong, K. L., Man, Y. B., Wong, L. Y. F., Lau, C., & Lam, K. S. L. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05414.x · Cited by 61
Ezenwaka, C. E., Akanji, A. O., Akanji, B., Unwin, N. C., & Adejuwon, C. A. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05991-6 · Cited by 60
Eriksson, J. W., Burén, J., Svensson, M. K. E., Olivecrona, T., & Olivecrona, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00366-0 · Cited by 61
Obesity, Fasting Plasma Insulin, and C‐Reactive Protein Levels in Healthy Children
Shea, S., Aymong, E. D., ZYBERT, P. A., Shamoon, H., Tracy, R. P., Deckelbaum, R. J., & Basch, C. E. (2003) · Obesity Research · doi:10.1038/oby.2003.15 · Cited by 61
Parkinson, C., Drake, W., Wieringa, G., Yates, A. P., BESSER, G. M., & Trainer, P. J. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01460.x · Cited by 61
An, P., Freedman, B. I., Hanis, C. L., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.3.909 · Cited by 61
Hamaguchi, K., Terao, H., Kusuda, Y., Yamashita, T., Bahles, J. A. H., Modesto Cruz, L. L., Luis Iván Brugal, V., Bienvenido Jongchong, W., Yoshimatsu, H., & Sakata, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031387 · Cited by 60
Moon, J. H., Kwak, S. H., Jung, H. S., Choi, S. H., Lim, S., Cho, Y. M., Park, K. S., Jang, H. C., & Cho, N. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1113 · Cited by 58
Oh, C., Jeon, B. H., Reid Storm, S. N., Jho, S., & No, J.-K. (2017) · Nutrition · doi:10.1016/j.nut.2016.06.004 · Cited by 60
Edwardson, C. L., Henson, J., Bodicoat, D. H., Bakrania, K., Khunti, K., Davies, M. J., & Yates, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014267 · Cited by 59
Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
Darmon, P., Dadoun, F., Boullu-Ciocca, S., Grino, M., Alessi, M.-C., & Dutour, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00654.2005 · Cited by 59
Ahmad, R., Thomas, R., Kochumon, S., & Sindhu, S. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.170 · Cited by 60
Pierce, J. R., Maples, J. M., & Hickner, R. C. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00575.2014 · Cited by 60
Yildizhan, R., Ilhan, G. A., Yildizhan, B., Kolusari, A., Adali, E., & Bugdayci, G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.073 · Cited by 60
Assessment of insulin resistance in lean women with polycystic ovary syndrome
Morciano, A., Romani, F., Sagnella, F., Scarinci, E., Palla, C., Moro, F., Tropea, A., Policola, C., Della Casa, S., Guido, M., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.04.004 · Cited by 62
The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis
for the DESIR study group, Bonnefond, A., Yengo, L., May, C. L., Fumeron, F., Marre, M., Balkau, B., Charpentier, G., Franc, S., Froguel, P., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3659-8 · Cited by 61
Li, S., Zhang, R., Pan, G., Zheng, L., & Li, C. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12596 · Cited by 61
Torquato, P., Giusepponi, D., Alisi, A., Galarini, R., Bartolini, D., Piroddi, M., Goracci, L., Veroli, A. D., Cruciani, G., Crudele, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37209-y · Cited by 62
Insulin Resistance and Colorectal Cancer Risk: the Role of Elevated Plasma Resistin Levels
Farahani, H., Mahmoudi, T., Asadi, A., Nobakht, H., Dabiri, R., & Hamta, A. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00260-7 · Cited by 62
Elkazzaz, S. K., Khodeer, D. M., Fayoumi, H. M. E., & Moustafa, Y. M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119018 · Cited by 60
Zhao, T., Zhan, L., Zhou, W., Chen, W., Luo, J., Zhang, L., Weng, Z., Zhao, C., & Liu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.647529 · Cited by 61
Dupuit, M., RANCE, M., MOREL, C., BOUILLON, P., BOSCARO, A., MARTIN, V., VAZEILLE, E., BARNICH, N., Chassaing, B., & Boisseau, N. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002809 · Cited by 81
Insulin resistance and incident heart failure: a meta‐analysis
Erqou, S. A., Adler, A., Challa, A. A., Fonarow, G. C., & Echouffo-Tcheugui, J. B. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2531 · Cited by 61
Li, S., Chen, S. X., Lu, X., Fang, A., Chen, Y., Huang, R.-Z., Lin, X., Huang, Z.-H., Ma, J.-F., Huang, B., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03581-7 · Cited by 63
Ding, E., Deng, F., Fang, J., Li, T., Hou, M., Liu, J., Miao, K., Yan, W., Fang, K., Shi, W., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp11896 · Cited by 64
Beals, J. W., Kayser, B. D., Smith, G. I., Schweitzer, G. G., Kirbach, K., Kearney, M. L., Yoshino, J., Rahman, G., Knight, R. D., Patterson, B. W., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00829-4 · Cited by 68
Yaikwawong, M., Jansarikit, L., Jirawatnotai, S., & Chuengsamarn, S. (2024) · Nutrition Journal · doi:10.1186/s12937-024-01022-3 · Cited by 62
Energetic adaptations persist after bariatric surgery in severely obese adolescents
Butte, N. F., Brandt, M. L., Wong, W. W., Liu, Y., Mehta, N. R., Wilson, T. A., Adolph, A. L., Puyau, M. R., Vohra, F. A., Shypailo, R. J., et al. (2015) · Obesity · doi:10.1002/oby.20994 · Cited by 55
Baker, P. R., Boyle, K. E., Koves, T. R., Ilkayeva, O., Muoio, D. M., Houmard, J. A., & Friedman, J. E. (2015) · Obesity · doi:10.1002/oby.21046 · Cited by 60
Association between Glucose Metabolism and Sleep-disordered Breathing during REM Sleep
Chami, H. A., Gottlieb, D. J., Redline, S. S., & Punjabi, N. M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0046oc · Cited by 66
Baier, L. J., Muller, Y. L., Remedi, M. S., Traurig, M. T., Piaggi, P., Wiessner, G. B., Huang, K., Stacy, A., Kobes, S., Krakoff, J. A., et al. (2015) · Diabetes · doi:10.2337/db15-0459 · Cited by 62
Otgonsuren, M., Stepanova, M., Gerber, L. H., & Younossi, Z. M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2446-3 · Cited by 60
Tsochatzis, E. A., Manolakopoulos, S., Papatheodoridis, G., & Archimandritis, A. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802273058 · Cited by 60
The dynamic insulin sensitivity and secretion test--a novel measure of insulin sensitivity.
McAuley, K., Berkeley, J., Docherty, P., Lotz, T., Morenga, L. T. T., Shaw, G., Williams, S. M., Chase, J. G., & Mann, J. I. (2011) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2011.05.009 · Cited by 57
Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes
Su, S., Pei, D., Hsieh, C., Hsiao, F., Wu, C., & Hung, Y.-J. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0171-y · Cited by 59
Bhatt, S. P., Nigam, P., Misra, A., Guleria, R., & Pasha, M. A. Q. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.006 · Cited by 60
Yeşilova, Z., Özata, M., Öktenli, Ç., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40838.x · Cited by 60
Kim, E., Park, D.-W., Choi, S.-H., Kim, J., & Cho, H.-S. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31816777f7 · Cited by 60
Tzeng, T.-F., Liou, S., & Liu, I. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/neq017 · Cited by 56
Fernandes‐Santos, C., Carneiro, R. E., Mendonça, L. D. S., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181987d9d · Cited by 60
Debono, M., Chadarévian, R., Eastell, R., Ross, R. J. M., & Newell-Price, J. D. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060984 · Cited by 60
de Asúa, D. R., Parra, P., da Costa, R. J. S., Moldenhauer, F., & Suárez, C. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.07.038 · Cited by 69
Klakk, H., Andersen, L., Heidemann, M., Møller, N., & Wedderkopp, N. (2014) · Scandinavian Journal of Public Health · doi:10.1177/1403494813505726 · Cited by 51
Kong, M. H., Lee, E., Lee, S.-Y., Cho, S., Hong, Y.-S., & Park, S.-B. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181405b74 · Cited by 60
Ashraf, H., Boroumand, M. A., Amirzadegan, A., Talesh, S. A., & Davoodi, G. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.011 · Cited by 60
Wang, Z. Q., Ribnicky, D., Zhang, X. H., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.015 · Cited by 60
Increased metabolic risk in adolescent offspring of mothers with type 1 diabetes: the EPICOM study
Vlachová, Z., Bytoft, B., Knorr, S., Clausen, T. D., Jensen, R. B., Mathiesen, E. R., Højlund, K., Ovesen, P., Beck‐Nielsen, H., Gravholt, C. H., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3589-5 · Cited by 58
McDonald, S. D., Ray, J. G., Teo, K. K., Jung, H., Salehian, O., Yusuf, S., & Lonn, E. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.04.020 · Cited by 60
Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Non-Diabetic Chinese Men
Xie, Y., Wang, M., Zhang, Y., Zhang, S., Tan, A., Gao, Y., Liang, Z., Shi, D., Zhang, H., Zhang, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067152 · Cited by 59
Regional fat distribution and cardiometabolic risk in healthy postmenopausal women
Peppa, Μ., Koliaki, C. C., Hadjidakis, D. I., Garoflos, E., Papaefstathiou, A., Katsilambros, N. L., Raptis, S., & Dimitriadis, G. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.07.001 · Cited by 60
Hatsuda, S., Shoji, T., Shinohara, K., Kimoto, E., Mori, K., Fukumoto, S., Koyama, H., Emoto, M., & Nishizawà, Y. (2006) · Journal of Vascular Research · doi:10.1159/000098153 · Cited by 60
Choi, K. M., Lee, K. W., Kim, S. G., Kim, N. H., Park, C. G., Seo, H. S., Oh, D. J., Choi, D. S., & Baik, S. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1795 · Cited by 60
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
